Search for: "DOCTORS ASSOCIATES INC." Results 1081 - 1100 of 1,874
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
6 Aug 2012, 2:29 pm
These reports came on the heels of similar news in Japan that regulators asked Boehringer Ingelheim to notify doctors about potentially deadly bleeding associated with the drug. [read post]
6 Aug 2012, 2:28 pm by Matthew David Brozik
Universal Television Network, Inc. is possibly the least sexy copyright decision of all time. [read post]
6 Aug 2012, 1:24 pm by Brenda Fulmer
This first lawsuit was filed in the San Francisco County Superior Court asserting that AstraZeneca Pharmaceuticals, Inc. and Takeda Pharmaceuticals USA, Inc. failed to conduct adequate and sufficient post-marketing surveillance of adverse events caused by ingestion of Nexium and Prevacid after they began marketing the drug. [read post]
6 Aug 2012, 4:50 am
Bard Inc. and a doctor over a vaginal-mesh implant that left a woman permanently injured. [read post]
27 Jul 2012, 12:40 pm by Bexis
Cephalon, Inc., 2010 WL 1257790, at *6 (D.N.J. [read post]
25 Jul 2012, 9:03 pm
These reports came on the heels of similar news in Japan that regulators asked Boehringer Ingelheim to notify doctors about potentially deadly bleeding associated with the drug. [read post]
25 Jul 2012, 4:03 pm by Leon Aussprung
These reports came on the heels of similar news in Japan that regulators asked Boehringer Ingelheim to notify doctors about potentially deadly bleeding associated with the drug. [read post]
25 Jul 2012, 4:03 pm by Leon Aussprung
These reports came on the heels of similar news in Japan that regulators asked Boehringer Ingelheim to notify doctors about potentially deadly bleeding associated with the drug. [read post]
25 Jul 2012, 4:03 pm by Leon Aussprung
These reports came on the heels of similar news in Japan that regulators asked Boehringer Ingelheim to notify doctors about potentially deadly bleeding associated with the drug. [read post]
20 Jul 2012, 12:50 pm by Zoe Tillman
The defendants in the case, which include Myriad Genetics Inc., have been fighting challenges to patents on two genes associated with breast and ovarian cancer. [read post]